Ke-Da Chen

Dr. Ke-Da Chen


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2023 in Cancer Medicine
Verified
Journal Article
Open access
QWQingjing Wang
Qingjing Wang
XSXueting Shao
Xueting Shao
YZYuxuan Zhang
Yuxuan Zhang
MZMiaojin Zhu
Miaojin Zhu
FWFrederick X. C. Wang
Frederick X. C. Wang
KCKe-Da Chen
Ke-Da Chen
Cancer is now considered a tumor microenvironment (TME) disease, although it was originally thought to be a cell and gene expression disorder. Over the past 20 years, significant advances have been made in understanding the complexity of the TME and its impact on responses to various anticancer therapies, including immunotherapies. Cancer immunotherapy can recognize and kill cancer cells by regulating the body's immune system. It has achieved good therapeutic effects in various solid tumors and hematological malignancies. Recently, blocking of programmed death‐1 (PD‐1), programmed death‐1 ligand‐1 (PD‐L1), and programmed death Ligand‐2 (PD‐L2), the construction of antigen chimeric T cells (CAR‐T) and tumor vaccines have become popular immunotherapies Tumorigenesis, progression, and metastasis are closely related to TME. Therefore, we review the characteristics of various cells and molecules in the TME, the interaction between PD‐1 and TME, and promising cancer immunotherapy therapeutics.

18 May 2023 in Frontiers in Microbiology
Verified
Journal Article
Open access
YZYimei Zhu
Yimei Zhu
YWYing Wang
Ying Wang
SZShuyang Zhang
Shuyang Zhang
JLJiaxuan Li
Jiaxuan Li
XLXin Li
Xin Li
QWQingjing Wang
Qingjing Wang
Dental caries is a common oral disease. In many cases, disruption of the ecological balance of the oral cavity can result in the occurrence of dental caries. There are many cariogenic microbiota and factors, and their identification allows us to take corresponding prevention and control measures. With the development of microbiology, the caries-causing bacteria have evolved from the traditional single Streptococcus mutans to the discovery of oral symbiotic bacteria. Thus it is necessary to systematically organized the association of polymicrobial interactions with dental caries development. In terms of ecology, caries occurs due to an ecological imbalance of the microbiota, caused by the growth and reproduction of cariogenic microbiota due to external factors or the disruption of homeostasis by one’s own factors. To reduce the occurrence of dental caries effectively, and considering the latest scientific viewpoints, caries may be viewed from the perspective of ecology, and preventive measures can be taken; hence, this article systematically summarizes the prevention and treatment of dental caries from the aspects of ecological perspectives, in particular the ecological biofilm formation, bacterial quorum sensing, the main cariogenic microbiota, and preventive measures.

9 August 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
ZFZhongbiao Fang
Zhongbiao Fang
JLJingting Lyu
Jingting Lyu
JLJianhua Li
Jianhua Li
CLChaonan Li
Chaonan Li
YZYuxuan Zhang
Yuxuan Zhang
KCKe-Da Chen
Ke-Da Chen
Bioreactors are widely used in cell culture-based viral vaccine production, especially during the coronavirus disease 2019 (COVID-19) pandemic. In this context, the development and application of bioreactors can provide more efficient and cost-effective vaccine production to meet the global vaccine demand. The production of viral vaccines is inseparable from the development of upstream biological processes. In particular, exploration at the laboratory-scale is urgently required for further development. Therefore, it is necessary to evaluate the existing upstream biological processes, to enable the selection of pilot-scale conditions for academic and industrial scientists to maximize the yield and quality of vaccine development and production. Reviewing methods for optimizing the upstream process of virus vaccine production, this review discusses the bioreactor concepts, significant parameters and operational strategies related to large-scale amplification of virus. On this basis, a comprehensive analysis and evaluation of the various process optimization methods for the production of various viruses (SARS-CoV-2, Influenza virus, Tropical virus, Enterovirus, Rabies virus) in bioreactors is presented. Meanwhile, the types of viral vaccines are briefly introduced, and the established animal cell lines for vaccine production are described. In addition, it is emphasized that the co-development of bioreactor and computational biology is urgently needed to meet the challenges posed by the differences in upstream production scales between the laboratory and industry.

12 November 2025 in npj Vaccines
Verified
Journal Article
Open access
PDF file
JLJiaxuan Li
Jiaxuan Li
GWGuangshang Wu
Guangshang Wu
ZHZhiwei Huang
Zhiwei Huang
JHJutao Hu
Jutao Hu
XTXiaotian Tie
Xiaotian Tie
KCKe-Da Chen
Ke-Da Chen
Respiratory mucosal immunity constitutes a critical barrier against pathogen invasion and has emerged as a promising target for vaccine development. This review outlines current understanding of its mechanisms, recent technological advances, and clinical progress. Compared with conventional vaccines, mucosal vaccines more effectively elicit localized and systemic immune responses. Key challenges and future directions are discussed, highlighting their potential in controlling emerging respiratory infections through improved immunological protection.

22 June 2022 in Bioengineering & Translational Medicine
Verified
Journal Article
Open access
YZYuxuan Zhang
Yuxuan Zhang
ZHZhiwei Huang
Zhiwei Huang
JZJiajie Zhu
Jiajie Zhu
CLChaonan Li
Chaonan Li
ZFZhongbiao Fang
Zhongbiao Fang
YZYanjun Zhang
Yanjun Zhang
The World Health Organization has reported approximately 430 million confirmed cases of coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), worldwide, including nearly 6 million deaths, since its initial appearance in China in 2019. While the number of diagnosed cases continues to increase, the need for technologies that can accurately and rapidly detect SARS‐CoV‐2 virus infection at early phases continues to grow, and the Federal Drug Administration (FDA) has licensed emergency use authorizations (EUAs) for virtually hundreds of diagnostic tests based on nucleic acid molecules and antigen–antibody serology assays. Among them, the quantitative real‐time reverse transcription PCR (qRT‐PCR) assay is considered the gold standard for early phase virus detection. Unfortunately, qRT‐PCR still suffers from disadvantages such as the complex test process and the occurrence of false negatives; therefore, new nucleic acid detection devices and serological testing technologies are being developed. However, because of the emergence of strongly infectious mutants of the new coronavirus, such as Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.1.529), the need for the specific detection of mutant strains is also increasing. Therefore, this article reviews nucleic acid‐ and antigen–antibody‐based serological assays, and compares the performance of some of the most recent FDA‐approved and literature‐reported assays and associated kits for the specific testing of new coronavirus variants.

1 April 2022 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
JZJiajie Zhu
Jiajie Zhu
HZHaiyan Zhang
Haiyan Zhang
QLQinghong Lin
Qinghong Lin
JLJingting Lyu
Jingting Lyu
LLLu Lu
Lu Lu
KCKe-Da Chen
Ke-Da Chen
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articlesor submit your research for publishing